Millions to benefit from drugmaker Eli Lilly's $35 cap on monthly insulin
Last Wednesday, drug producer Eli Lilly announced that the out-of-pocket cost of its insulin will be capped at $35 per month. According to experts, the action could lead other U.S. insulin manufacturers to follow. The adjustment, which Eli Lilly says is effective immediately, brings the Read More...